Ignite Creation Date:
2025-12-24 @ 2:00 PM
Ignite Modification Date:
2026-02-22 @ 4:14 PM
Study NCT ID:
NCT02293395
Status:
COMPLETED
Last Update Posted:
2017-12-26
First Post:
2014-11-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
Sponsor:
Janssen Research & Development, LLC
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Acute Coronary Syndrome | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Acute Coronary Syndrome | View |
| None | Myocardial infarction | View |
| None | Unstable angina | View |
| None | Acetylsalicylic acid | View |
| None | Rivaroxaban | View |
| None | JNJ-39039039 | View |
| None | Bay 59-7939 | View |
| None | Xarelto | View |
| None | Clopidogrel | View |
| None | Ticagrelor | View |
| None | Plavix | View |
| None | Brilinta | View |
| None | Effient | View |